References
- CairnsJDrummondMMcGuireADiscounting in economic evaluationEconomic evaluation in healthcare2001OxfordOxford University Press Ch 10
- [CCOHTA] Canadian Coordinating Office for Health Technology AssessmentGuidelines for economic evaluation of pharmaceuticals: Canada19972OttawaCanadian Coordinating Office for Health Technology Assessment
- Colleges Des Économistes De La SantéFrench guidelines for the economic evaluation of healthcare technologies [online]2004 Accessed Apr 10 2006. URL:http://www.ispor.org/PEguidelines/source/France_Guidelines_HE_Evaluation.pdf
- DRG handbookComparative clinical and financial benchmarks, HCIA-Sachs, LLC and Ernst&Young LLP2000
- DrummondMMcGuireAEconomic evaluation in healthcare2001OxfordOxford University Press
- ISPOR Budget Impact Analysis Task ForcePrinciples of good practice for budget impact analysis [online]2007 Accessed Apr 30 2007. URL: http://www.ispor.org/workpaper/budget_impact.asp
- KuntzKWeinsteinMDrummondMMcGuireAModelling in economic evaluationEconomic evaluation in healthcare: merging theory with practice2001Oxford, UKOxford University Press
- [NICE] National Institute for Clinical ExcellenceGuide to the Methods of Technology Appraisal [online]2004 Accessed Apr 10 2006. URL: http://www.nice.org.uk/pdf/TAP_Methods.pdf
- National Research CouncilImproving Information for Social Policy Decisions: The Uses of Microsimulation Modeling, Vol. 1, Review and Recommendations1991WashingtonNational Academy Press
- O’BrienAShompheLAKavanaghPLDirect medical costs of complications resulting from type 2 diabetes in the USDiabetes Care199821112289653606
- [PBAC] Pharmaceutical Benefits Advisory CommitteeGuidelines for the pharmaceutical industry on preparation of submissions to the Pharmaceutical Benefits Advisory Committee [online]2002 Accessed Apr 10 2006. URL: http://www.health.gov.au/internet/wcms/publishing.nsf/Content/health-pbs-general-pubs-guidelines-index.htm
- Pharmaceutical Benefits BoardGeneral guidelines for economic evaluation from the Pharmaceutical Benefits Board [online]2003 Accessed Apr 10 2006. URL: http://www.lfn.se/upload/English/ENG_lfnar2003-eng.pdf
- Resource utilization and costs of care in the diabetes control and complications trialDiabetes Care1995181468788722072
- StockSAKRedaelliMWendlandGDiabetes – prevalence and cost of illness in Germany: a study evaluating data from the statutory health insurance in GermanyDiabetic Med20052329930516492214
- TruemanPDrummondMHuttonJDeveloping guidance for budget impact analysisPharmacoeconomics2001166092111456210
- [UKPDS] Prospective Diabetes Study GroupIntensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)Lancet1998352837539742976
- ZweifelPBreyerFHealth economics1997New YorkOxford University Press